Clinical Chemistry, Malmö
1 – 10 of 1356
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma
- Contribution to journal › Article
-
Mark
A Proteomic Study of the Dual Oncogenic and Tumor-Suppressive Roles of SIRT3 in Lung and Breast Cancer Cell Lines
- Contribution to journal › Article
-
Mark
SPAP : Soluble Human Plasma Proteoform Analysis via Acetonitrile Precipitation and Top-Down Mass Spectrometry
- Contribution to journal › Article
-
Mark
A 25-year evaluation of direct local international normalized ratio calibration of the Owren type prothrombin time method in Sweden
(2026) In Journal of Thrombosis and Haemostasis
- Contribution to journal › Article
-
Mark
Evaluation of a Particle Enhanced Turbidimetric Immunoassay (PETIA) for detecting calprotectin in sputum samples
- Contribution to journal › Article
- 2025
-
Mark
High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients
- Contribution to journal › Article
-
Mark
Prophylactic cranial irradiation for small cell lung cancer in the era of immunotherapy and molecular subtypes
- Contribution to journal › Scientific review
-
Mark
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups
- Contribution to journal › Article
-
Mark
Importance of individual residues in hydrophobic patch PLVIVGL (1481-1487) in FV-Short for synergistic TFPIα cofactor activity with protein S, an alanine-scanning study: AlphaFold-mediated prediction of FV-Short/TFPIα/protein S trimolecular complex structure
- Contribution to journal › Article
-
Mark
Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk
- Contribution to journal › Debate/Note/Editorial
